Stereotaxis receives FDA clearance for MAGiC Sweep catheter
Evidence notes
- Stereotaxis received U.S. FDA clearance for MAGiC Sweep, a robotically steered endovascular guide catheter.
- The company described the clearance as its first FDA clearance for an interventional catheter in nearly 20 years.
- The milestone supports the company's robotic magnetic navigation profile with a cleared device update.
Company context
Stereotaxis develops robotic magnetic navigation systems for minimally invasive endovascular procedures, with Genesis as its core robotic platform.